KHYG-1 Cells

Name: CLS Cell Lines Service GmbH
Address: Dr.-Eckener-Straße 8, Eppelheim, 69214, DE
Telephone: +496221405780
Price range: €€€

USD 500.00*

Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10⁶ cells for adherent lines or 5 × 10⁶ cells for suspension lines (refer to the batch CoA for details).

Los precios no incluyen impuestos ni gastos de envío

cryovial

Número de producto: 305890

Ficha de datos de seguridad

Ficha del producto

Certificado de análisis (CoA)

Descripción	KHYG-1 is a human natural killer (NK) cell leukemia cell line established from the peripheral blood of an adult female patient diagnosed with aggressive NK-cell leukemia. The cell line was derived at initial diagnosis and represents an Epstein-Barr virus (EBV)-negative NK-cell malignancy, distinguishing it from many NK/T-cell lymphoma models that are EBV-associated. KHYG-1 cells grow in suspension and display the cytomorphologic and immunophenotypic characteristics of activated NK cells, including expression of CD56 and cytoplasmic CD3ε, while lacking surface CD3 and T-cell receptor gene rearrangements, consistent with true NK-cell lineage derivation. Molecular profiling studies have included KHYG-1 in genomic and transcriptomic analyses of NK-cell malignancies. Array comparative genomic hybridization and gene expression studies across NK-cell lines have identified recurrent chromosomal abnormalities in NK-cell tumors, such as deletions involving 6q21 and alterations affecting tumor suppressor pathways. In contrast to several EBV-positive NK-cell lines, KHYG-1 does not harbor detectable ATR gene alterations in analyses of the full coding region, underscoring molecular heterogeneity within NK-cell neoplasms. Gene expression profiling places KHYG-1 within the NK-cell lineage cluster, characterized by expression of NK-associated receptors and cytotoxic effector molecules, and distinct from cytotoxic αβ and γδ T-cell lymphomas. Functionally, KHYG-1 exhibits interleukin-2-dependent proliferation in vitro and retains cytotoxic activity typical of NK cells. The line has been widely used to investigate signaling pathways critical to NK-cell survival and proliferation, including aurora kinase A and NOTCH pathway components, as well as to evaluate candidate therapeutic inhibitors targeting NK-cell malignancies. As an EBV-negative model of aggressive NK-cell leukemia, KHYG-1 provides a valuable in vitro system for studying intrinsic oncogenic mechanisms in NK-cell transformation, independent of viral-driven lymphomagenesis.
Organismo	Human
Tejido	Peripheral blood
Enfermedad	Natural killer cell lymphoblastic leukemia/lymphoma
Sinónimos	KHYG1, KHYG

Edad	45 years
Género	Female
Origen étnico	Japanese
Morfología	lymphocyte-like
Propiedades de crecimiento	Floating aggregates Cluster

Referencia	KHYG-1 (Cytion catalog number 305890)
Nivel de bioseguridad	1
NCBI_TaxID	9606
N.º de acceso de Cellosaurus	CVCL_2976

Perfil mutacional	Mutation: p.Gly12Ala, Unspecified; Mutation: p.Arg248Trp, Unspecified

Medio de cultivo	RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Suplementos	Supplement the medium with 10% heat-inactivated FBS and 10 ng/ml IL-2
Reactivo de disociación	None
Tiempo de duplicación	24-48 hours ; ~30-40 hours ; ~54 hours , ~30 hours , ~25 hours
Relación de división	Split 1/4 every 3-4 days.
Renovación de fluidos	Simple dilution because of suspension cell culture. Subculture every 3-4 days with split ratio = 1/4.
Medio de congelación	As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Descongelación y cultivo de células	Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium. Follow the procedure described under Post-Thaw Recovery
Atmósfera de incubación	37°C, 5% CO₂, humidified atmosphere.
Condiciones de envío	Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.
Condiciones de almacenamiento	For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Número de lote	Tipo de certificado	Fecha	Número de catálogo
305890-171125	Certificado de análisis	15. Jan. 2026	305890

KHYG-1 Cells

Información general

Características

Datos normativos

Datos biomoleculares

Manejo

Control de calidad y análisis molecular

Certificado de análisis (CoA)